Conclusion Among persons with opioid dependence, the use of buprenorphine implants compared with placebo resulted in less opioid use over 16 weeks as assessed by urine samples.
Trial Registration clinicaltrials.gov Identifier: NCT00447564 (Source: JAMA)
Buprenorphine Implants for Treatment of Opioid Dependence: A Randomized Controlled Trial [Original Contribution]
Previous post: Addiction Psychiatric Assessment and Oxycontin Treatment : Part 1
Next post: FDA Approves Sublingual Film Formulation of Buprenorphine/Naloxone
